Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection

INTRODUCTION: Plasma harvested from convalescent COVID-19 patients (CCP) has been applied as first-line therapy in the early phase of the SARS-CoV2 pandemic through clinical studies using various protocols. METHODS: We present data from a cohort of 267 hospitalized severe COVID-19 patients who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Fodor, Eszter, Müller, Veronika, Iványi, Zsolt, Berki, Tímea, Kuten Pella, Olga, Hornyák, István, Ambrus, Mira, Sárkány, Ágnes, Skázel, Árpád, Madár, Ágnes, Kardos, Dorottya, Kemenesi, Gábor, Földes, Fanni, Nagy, Sándor, Matusovits, Andrea, János, Nacsa, Tordai, Attila, Jakab, Ferenc, Lacza, Zsombor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611245/
https://www.ncbi.nlm.nih.gov/pubmed/34817840
http://dx.doi.org/10.1007/s40121-021-00514-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611245/
https://www.ncbi.nlm.nih.gov/pubmed/34817840
http://dx.doi.org/10.1007/s40121-021-00514-7

Ejemplares similares